-
公开(公告)号:US10155002B2
公开(公告)日:2018-12-18
申请号:US15346677
申请日:2016-11-08
Applicant: Epizyme, Inc.
Inventor: Kevin Wayne Kuntz , Richard Chesworth , Kenneth William Duncan , Heike Keilhack , Natalie Warholic , Christine Klaus , Sarah Kathleen Knutson , Timothy James Nelson Wigle , Masashi Seki , Syuji Shirotori , Satoshi Kawano
IPC: A61K31/5377 , C07D498/08 , C07D213/64 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/08 , C07D491/107 , C07D405/14 , A61K31/4412 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/551 , A61K31/553
Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
-
公开(公告)号:US09855275B2
公开(公告)日:2018-01-02
申请号:US15598078
申请日:2017-05-17
Applicant: Epizyme, Inc.
Inventor: Kevin W. Kuntz , Richard Chesworth , Kenneth W. Duncan , Heike Keilhack , Natalie Warholic , Christine Klaus , Sarah K. Knutson , Timothy J. N. Wigle , Masashi Seki , Syuji Shirotori , Satoshi Kawano
IPC: A61K31/5377 , A61K31/444 , A61K31/506 , A61K31/4412 , A61K31/553 , A61K31/551 , C07D213/64 , C07D409/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D491/08 , C07D491/107 , C07D405/14 , C07D498/08 , A61K31/496 , A61K31/4709 , A61K31/4545 , A61K31/4439 , A61K31/4436 , A61K31/4433 , A61K31/443 , C07D401/12
CPC classification number: A61K31/5377 , A61K31/4412 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/551 , A61K31/553 , C07D213/64 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/08 , C07D491/107 , C07D498/08
Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
-
公开(公告)号:US09688665B2
公开(公告)日:2017-06-27
申请号:US14054646
申请日:2013-10-15
Applicant: Epizyme, Inc.
Inventor: Sarah K. Knutson , Natalie Warholic , Heike Keilhack
IPC: A61K31/5377 , C07D405/14 , C07D211/86 , C07D405/12 , C12Q1/68 , A61K31/4412 , A61K31/4545
CPC classification number: C07D405/14 , A61K31/4412 , A61K31/4545 , A61K31/5377 , C07D211/86 , C07D405/12 , C12Q1/6886
Abstract: The present invention relates to methods of treating cancer by administering the EZH2 inhibitor compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
-
公开(公告)号:US20170119780A1
公开(公告)日:2017-05-04
申请号:US15346677
申请日:2016-11-08
Applicant: Epizyme, Inc.
Inventor: Kevin Wayne Kuntz , Richard Chesworth , Kenneth William Duncan , Heike Keilhack , Natalie Warholic , Christine Klaus , Sarah Kathleen Knutson , Timothy James Nelson Wigle , Masashi Seki , Syuji Shirotori , Satoshi Kawano
IPC: A61K31/5377 , A61K31/444 , A61K31/4545 , A61K31/4439 , A61K31/4433 , A61K31/4436 , A61K31/551 , A61K31/553 , A61K31/506 , A61K31/443 , A61K31/4709 , A61K31/4412 , A61K31/496
CPC classification number: A61K31/5377 , A61K31/4412 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/551 , A61K31/553 , C07D213/64 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/08 , C07D491/107 , C07D498/08
Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
-
-
-